Clinical Trial Update: Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety, tolerability, and early bactericidal activity of RESP30TB in pulmonary tuberculosis. The study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• RESP30TB

Snippet

Sponsor: Thirty Respiratory Limited | Conditions: Pulmonary Tuberculoses | Phase 2 | Status: RECRUITING